Structure-based virtual screening and lead identification of novel protein kinase inhibitors through integrated computational approaches
- 22 July 2026
- journal article
- research article
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 15 (1) , 162
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Targeting p53–MDM2 pathway with novel triazole–oxazole hybrids: a fragment-based drug discovery approach for next-generation cancer therapiesMolecular Diversity, 2025
- Identification of new dasatinib analogues targeting mutated BCR-ABL1: virtual screening, molecular docking, and dynamics simulations studiesMolecular Diversity, 2025
- Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New DrugsChemBioChem, 2024
- Dual roles of ATP-binding site in protein kinases: Orthosteric inhibition and allosteric regulation2021
- Computational Approaches in Drug Discovery and Design2020
- Overview of Current Type I/II Kinase Inhibitors2020
- Modeling conformational flexibility of kinases in inactive statesProteins: Structure, Function, and Bioinformatics, 2019
- Jaguar: A high‐performance quantum chemistry software program with strengths in life and materials sciencesInternational Journal of Quantum Chemistry, 2013
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, Function, and Bioinformatics, 2011